Shares in SRx Health Solutions (SRXH) surged more than 100% to over $0.60 per share on Tuesday morning after the Canadian healthcare services provider announced plans to undergo a reverse merger with the digital asset treasury company EMJ Crypto Technologies in a $55 million deal.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
A reverse merger is a transaction in which a private company becomes publicly traded by combining with an existing listed company instead of pursuing a traditional initial public offering.
It is not clear whether the merger represents a change in business direction for the Ontario-based company, which offers specialty healthcare services, including pet wellness, across Canada. The move could also be the addition of an entirely new business type to SRx Health’s business focus under a new name.
What Does EMJ Crypto Technologies Do?
As a digital treasury management platform, EMJ Crypto Technologies, under the EMJX brand, uses quantitative financial models, artificial intelligence, and built-in risk controls to manage multiple digital assets. This helps to manage asset exposure during market bull runs and contractions.
Following the merger, SRx Health noted that fund manager and activist investor Eric Jackson, who is the founder and chief executive at EMJX, will lead the newly merged entity that will opt for the EMJX brand name. Jackson will also serve as chairman of the new merged company.
SRx Health Merger to Close in 2026
The arrangement has been approved by SRx Health’s board of directors, but it still needs the green light from shareholders. The deal is expected to close during the first quarter of next year.
After completion, SRx Health will retire the ticker symbol “SRXH” from the New York Stock Exchange American, where it is traded. However, it will continue to trade publicly under a new symbol.
Is SRXH a Good Stock to Buy?
TipRanks’ AI Analyst, based on OpenAI-4o, currently rates SRx Health’s shares as Neutral. The analyst points to the company’s declining revenues and negative cash flow for the rating.
The ranking comes in with a score of 48 out of 100 with a price target of $0.50, implying about 9% downside risk.
